IBL HealthCare Statistics
Total Valuation
IBL HealthCare has a market cap or net worth of PKR 4.22 billion. The enterprise value is 4.59 billion.
| Market Cap | 4.22B |
| Enterprise Value | 4.59B |
Important Dates
The last earnings date was Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBL HealthCare has 98.53 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 98.53M |
| Shares Outstanding | 98.53M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 6.51% |
| Float | 26.78M |
Valuation Ratios
The trailing PE ratio is 19.79.
| PE Ratio | 19.79 |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.30, with an EV/FCF ratio of -201.71.
| EV / Earnings | 21.43 |
| EV / Sales | 1.09 |
| EV / EBITDA | 10.30 |
| EV / EBIT | 10.51 |
| EV / FCF | -201.71 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.95 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.02 |
| Debt / FCF | -19.90 |
| Interest Coverage | 9.43 |
Financial Efficiency
Return on equity (ROE) is 9.21% and return on invested capital (ROIC) is 8.58%.
| Return on Equity (ROE) | 9.21% |
| Return on Assets (ROA) | 6.96% |
| Return on Invested Capital (ROIC) | 8.58% |
| Return on Capital Employed (ROCE) | 17.83% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | 18.83M |
| Profits Per Employee | 955,080 |
| Employee Count | 224 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, IBL HealthCare has paid 173.43 million in taxes.
| Income Tax | 173.43M |
| Effective Tax Rate | 44.77% |
Stock Price Statistics
The stock price has increased by +26.82% in the last 52 weeks. The beta is 0.31, so IBL HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +26.82% |
| 50-Day Moving Average | 57.01 |
| 200-Day Moving Average | 54.93 |
| Relative Strength Index (RSI) | 26.25 |
| Average Volume (20 Days) | 158,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IBL HealthCare had revenue of PKR 4.22 billion and earned 213.94 million in profits. Earnings per share was 2.16.
| Revenue | 4.22B |
| Gross Profit | 1.57B |
| Operating Income | 436.22M |
| Pretax Income | 387.37M |
| Net Income | 213.94M |
| EBITDA | 441.10M |
| EBIT | 436.22M |
| Earnings Per Share (EPS) | 2.16 |
Balance Sheet
The company has 87.62 million in cash and 452.47 million in debt, giving a net cash position of -364.85 million or -3.70 per share.
| Cash & Cash Equivalents | 87.62M |
| Total Debt | 452.47M |
| Net Cash | -364.85M |
| Net Cash Per Share | -3.70 |
| Equity (Book Value) | 2.43B |
| Book Value Per Share | 24.35 |
| Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was -477,000 and capital expenditures -22.26 million, giving a free cash flow of -22.73 million.
| Operating Cash Flow | -477,000 |
| Capital Expenditures | -22.26M |
| Free Cash Flow | -22.73M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 37.25%, with operating and profit margins of 10.34% and 5.07%.
| Gross Margin | 37.25% |
| Operating Margin | 10.34% |
| Pretax Margin | 9.18% |
| Profit Margin | 5.07% |
| EBITDA Margin | 10.46% |
| EBIT Margin | 10.34% |
| FCF Margin | n/a |
Dividends & Yields
IBL HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.01% |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.36% |
| Earnings Yield | 5.07% |
| FCF Yield | -0.54% |
Stock Splits
The last stock split was on October 7, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Oct 7, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
IBL HealthCare has an Altman Z-Score of 3.66 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 4 |